<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68">
 <label>68</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahadeo</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Khazal</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Abdel-Azim</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Fitzgerald</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Taraseviciute</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Bollard</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy</article-title>. 
  <source>Nat Rev Clin Oncol</source> (
  <year>2019</year>) 
  <volume>16</volume>(
  <issue>1</issue>):
  <fpage>45</fpage>–
  <lpage>63</lpage>.  
  <pub-id pub-id-type="doi">10.1038/s41571-018-0075-2</pub-id>
  <pub-id pub-id-type="pmid">30082906</pub-id>
 </mixed-citation>
</ref>
